Ignite Creation Date:
2025-12-25 @ 4:49 AM
Ignite Modification Date:
2026-01-22 @ 8:12 AM
Study NCT ID:
NCT05575518
Status:
RECRUITING
Last Update Posted:
2023-08-25
First Post:
2022-10-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Pragmatic Trial With Optimized Dose of Rifampicin and Moxifloxacin for the Treatment of Drug Susceptible Pulmonary Tuberculosis
Sponsor:
Stellah Mpagama
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-08-11
Start Date Type:
ACTUAL
Primary Completion Date:
2025-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-03-31
Completion Date Type:
ESTIMATED
First Submit Date:
2022-10-06
First Submit QC Date:
None
Study First Post Date:
2022-10-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-23
Last Update Post Date:
2023-08-25
Last Update Post Date Type:
ACTUAL